Your browser doesn't support javascript.
loading
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies.
Curry, Michael P; Vargas, Hugo E; Befeler, Alex S; Pyrsopoulos, Nikolaos T; Patwardhan, Vilas R; Jamil, Khurram.
Affiliation
  • Curry MP; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Vargas HE; Mayo Clinic, Phoenix, Arizona, USA.
  • Befeler AS; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Saint Louis University, St. Louis, Missouri, USA.
  • Pyrsopoulos NT; Division of Gastroenterology and Hepatology, Liver Transplantation, Rutgers-New Jersey Medical School University Hospital, Newark, New Jersey, USA.
  • Patwardhan VR; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Jamil K; Mallinckrodt Pharmaceuticals, Clinton, New Jersey, USA.
Hepatol Commun ; 7(1): e1307, 2023 01 01.
Article in En | MEDLINE | ID: mdl-36633470
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vasoconstrictor Agents / Hepatorenal Syndrome Type of study: Clinical_trials / Etiology_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Hepatol Commun Year: 2023 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vasoconstrictor Agents / Hepatorenal Syndrome Type of study: Clinical_trials / Etiology_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Hepatol Commun Year: 2023 Type: Article Affiliation country: United States